Is Lantern Pharma Inc. overvalued?

Lantern Pharma Inc. (LTRN) — key valuation metrics and fundamentals.

No verdict

Price

$2.65

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$33.8M

Dividend yield

0.0%

Return on equity

-198.3%

Sector

Healthcare

Fair value compares LTRN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks